A comparison of the acute pathology induced by 3-phenylamino-1,2-propanediol (PAP) and its mono-oleoyl ester in rodents with the toxic oil syndrome in man

Abstract

Phenylamino-1,2 propanediol (PAP) and its mono-oleoyl ester have been identified in samples of the cooking oil thought to be responsible for the Toxic Oil Syndrome (TOS) which occurred in Spain in 1981. The acute toxicity of PAP and its mono-oleoyl ester have been examined in rats and mice, after daily administration for periods of up to 14 days to determine whether these compounds could produce any of the pathologies of TOS. Even at the highest dose, the 1-mono-oleoyl ester of 3-phenylamino-1,2 propanediol did not cause any toxicity in rats or mice when given intraperitoneally. 3-Phenylamino-1,2 propane diol, however, was toxic when administered to rats by this route. After 6-10 consecutive daily doses of PAP, at the highest dose administered (350 mg kg^-1), all of the rats became unwell. Postmortem examination showed that the major pathology present was massive pulmonary throm boembolism. Further investigations of the toxicity of PAP after intravenous administration showed that it was not directly vasotoxic. The pulmonary thromboembolism seen with intraperitoneally administered PAP was due to the toxic effect of PAP on the mesenteric tissue and blood ves sels, causing thrombosis which subsequently embolised the blood vessels in the lung. Intra-gastric administration of PAP caused no toxicity in rats. Comparatively, the pathology seen after intraperitoneal administration of PAP was not thought to be representative of the pathology of the toxic oil syndrome in man.

Keywords

rodent toxicity 3-phenylamino-1,2 propanedi ol toxic oil syndrome pulmonary toxicity peritoneal toxi city

Get full access to this article

View all access options for this article.

References

Aldridge WN The Toxic Oil Syndrome (TOS, 1981): from the disease towards a toxicological understanding of its chemical aetiology and mechanism. Toxicology Letters 1992; 64/65: 59-70.

Altenkirch H. , Stoltenburg-Didinger G. & Koeppel C. The neurotoxicological aspects of the toxic oil syndrome (TOS) in Spain. Toxicology 1988; 49: 25-34.

Toxic epidemic syndrome study group. Toxic epidemic syndrome, Spain, 1981 . Lancet 1982; September 25: 697-702.

Posada de la Paz M , Araitua Borda I , Kilbourne EM , Tabuenica Oliver JM , Diaz de Rojas F & Castro Garcia M. Late cases of toxic oil syndrome: evidence that the aetiological agent persisted in oil stored for up to one year. Food & Chemical Toxicology 1989; 27 : 517-21.

Kammuller ME , Penninks AH & Seinen W. Spanish toxic oil syndrome is a chemically induced GVHDlike epidemic. Lancet 1984 ; May 26: 1174-5.

Khan MF , Kaphalia BS , Palafox A. , Jerrella TR & Ansari Gas. Toxicity of oleic acid anilide in rats. Archives of Environmental Contamination & Toxicology 1991; 21: 571-7.

Beaubernard C. , Spencer PS , Koeppel , C. & Altenkirch , H. "Spanish Oil" not neurotoxic to rats. Lancet 1982; ii: 1278-9.

Aldridge WN & Connors TA Toxic oil syndrome in Spain. Food & Chemical Toxicology 1983; 20 : 989-92.

Cunningham VJ , Tucker SP & Bailey E. Hydrolysis of oleylanilide in the rat. Archives of Toxicology 1983; 54: 157-62.

10.

Maestro Duran R. , Ruiz Gutiérrez , V. & Vazquez Roncero A. Toxic oil syndrome in Spain: Toxicological study in mice of new aniline derivatives present in toxic oils. Erasas y aceites, 1986; 37: 207-14.

11.

Crofford LJ , Rader JI , Dalakas MC et al. L-Tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat. Journal of Clinical Investigation 1990; 86: 1757-63.

12.

Ferrer M. , Galceran M. , Sanchez-Baeza F. , Casas J. & Messeguer A. Synthesis of aniline derivatives with potential toxicological implications to the Spanish Toxic Oil Syndrome. Liebigs Annalen der Chemie 1993; No.5: 507-11.

13.

Martinez-Tello FJ , Navos-Palacios JJ , Ricoz JR , Gil-Martin R. , Conde-Zurita JM , Colina-Ruiz , Delgado F. , Tellez I. , Cabello A. & Madero-Garcia S. Pathology of a new toxic syndrome caused by ingestion of adulterated oil in Spain . Virchows Archiv Pathological Anatomy 1982; 397: 261-85.

14.

Ricoy JR , Cabello A. , Rodriguez J. & Tellez I. Neuropathological studies on the toxic syndrome related to adulterated rapeseed oil in Spain. Brain 1983; 106: 817-35.